AMGN vs CAH
By Alex · Tickerpine
Amgen Inc. vs Cardinal Health, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | AMGN | CAH |
|---|---|---|
| Price | $416.18 | $234.16 |
| Market cap | $225.15B | $54.46B |
| P/E ratio | 25.7 | 33.2 |
| ROE | 91.47% | — |
| Profit margin | 22.95% | 0.67% |
| Revenue growth | 9.50% | 5.80% |
| Dividend yield | 2.43% | 0.86% |
| Beta | 0.41 | — |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
AMGN vs CAH in plain English
- AMGN is the bigger company — about 4.1× the market cap of CAH.
- AMGN is cheaper on earnings (P/E 25.7 vs 33.2).
- AMGN is growing revenue faster (10% vs 6%).
- AMGN has the higher dividend yield (2.43% vs 0.86%).
How would $1,000 have done in each?
AMGN return calculator
See what $1,000 in Amgen Inc. would be worth today.
CAH return calculator
See what $1,000 in Cardinal Health, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.